---
title: Crystec Limited (CrystecPharma) vs Gannet Biochem
slug_a: crystecpharma
slug_b: gannetbiochem
site: cdmo
review_signal_gate: closed
canonical_path: /compare/crystecpharma/gannetbiochem
---

# Crystec Limited (CrystecPharma) vs Gannet Biochem

Side-by-side profile data from each company listing on this directory.

## Crystec Limited (CrystecPharma)

- Profile: [/companies/crystecpharma](/companies/crystecpharma)

Crystec Limited (CrystecPharma) — Crystec Limited (CrystecPharma) is a pharmaceutical technology company that offers its mSAS® supercritical-fluid particle engineering platform to improve the bioavailability, stability and delivery of small and large molecule therapeutics. Its work is aimed at clients developing new and existing medicines.

Services: 4. Modalities: 5. Indications: 1. Locations: 4. Certifications: 0. The strongest documented coverage currently appears in modalities (5).

### Services

- Solid-State Chemistry & Polymorph Screening
- Inhalation & Nasal Dosage Manufacturing
- Process Development
- Formulation Development

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Oligonucleotide
- Peptide

### Development capabilities

- Formulation development

### Manufacturing capabilities

- Data not yet provided.

## Gannet Biochem

- Profile: [/companies/gannetbiochem](/companies/gannetbiochem)

Gannet Biochem — Gannet BioChem is a specialized CDMO focused on activated polymer, PEG, and bioconjugation services for complex therapeutics, from early development through cGMP manufacturing. It operates facilities in Huntsville and Arab, Alabama.

Services: 13. Modalities: 4. Indications: 0. Locations: 4. Certifications: 1. The strongest documented coverage currently appears in services (13).

### Services

- Analytical Method Development & Validation
- ICH Stability Studies
- Small Molecule Development & Manufacturing
- Biologics Development & Manufacturing
- Recombinant Protein Manufacturing
- Bioconjugation Services
- Process Development
- Formulation Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Peptide

### Development capabilities

- Analytical method development
- Formulation development
- ICH stability testing

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Max chemical: Commercial (>100 kg / tonne)